StockData
Clearmind Medicine Inc. logo

Clearmind Medicine Inc. (CMND) stock

CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Score 5/30
$3.45−0.73 (-17.52%)

Close on Nov 17, 2026Market cap $545.36KP/E –Yield –

Clearmind Medicine market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Clearmind Medicine's market cap was $629.11K on Nov 11, 2026, against $38.34M a year earlier. Over the last 5 years it ranged from $629.11K to $1.40B, with a median of $41.31M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$629.11K-94.4%
2025Dec 31, 2025$11.22M-49.8%
2024Dec 31, 2024$22.35M+129.5%
2023Dec 29, 2023$9.74M-97.1%
2022Dec 30, 2022$333.73M-49.9%
2021Dec 31, 2021$665.50M–

More Clearmind Medicine figures

See a number that looks wrong?